Vaccine effectiveness against the B.1.617.2 in the intensive care unit

Severe acute respiratory syndrome-coronavirus 2 and its variants are still a concern for the World. The effectiveness of the BioNTech and Sinovac vaccines against the B.1.617.2 variant, particularly in the intensive care unit, has been unclear. This study aimed to investigate the vaccine effectivene...

Descripción completa

Detalles Bibliográficos
Autores principales: Koc, Ibrahim, Unalli Ozmen, Sevda, Deniz, Olgun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589509/
https://www.ncbi.nlm.nih.gov/pubmed/37861554
http://dx.doi.org/10.1097/MD.0000000000035588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589509/
https://www.ncbi.nlm.nih.gov/pubmed/37861554
http://dx.doi.org/10.1097/MD.0000000000035588

Ejemplares similares